Mina Sooch - Jan 28, 2022 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
President and CEO, Director
Signature
/s/ Jeffrey Kuras, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Jan 28, 2022
Transactions value $
$0
Form type
4
Date filed
2/1/2022, 03:26 PM
Next filing
May 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Employee Stock Option (right to buy) Award $0 +200K $0.00 200K Jan 28, 2022 Common Stock 200K $2.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest with respect to 50,000 shares on January 28, 2023, and then with respect to 4,166 shares on the last day of each month from February 2023 through December 2025 and with respect to 4,190 shares at the end of January 2026.